PURPOSE: To investigate the clinical presentation, isolated organism, treatment, and morbidity of contact lens-associated microbial keratitis needing hospitalization. METHODS: This retrospective study included all consecutive patients with contact lens-associated microbial keratitis hospitalized in the Rotterdam Eye Hospital from January 1, 2005, to December 31, 2009. All data regarding epidemiological characteristics, clinical presentation, isolated organism, and treatment were collected from medical records. RESULTS: There were 109 cases (108 patients) of contact lens-associated microbial keratitis hospitalized during the study period. Mean age was 33.3 ± 15.4 (SD) years. Pseudomonas aeruginosa was the most frequently isolated microorganism (68.8 %), with minor resistance to gentamicin (2.7 %) and ofloxacin (1.3 %). At time of presentation, best corrected visual acuity (BCVA) was very poor, with the largest proportion of patients (65.1 %) seeing worse than 0.05 Snellen. After intensive treatment, the visual outcome improved considerably, with the largest proportion (67.0 %) achieving a BCVA ≥ 0.7 Snellen. Low BCVA at admission was significantly associated with a worse final BCVA. A total of 22 patients (20.2 %) required corneal transplantation (three emergency cases). Larger size of stromal infiltrate was significantly associated with the need for corneal transplantation. CONCLUSION: Microbial keratitis is a serious complication of contact lens wear, with approximately one out of five hospitalized cases requiring corneal transplantation. Ofloxacin, or a combination of gentamicin and cephazolin, still appear to be excellent first-choice therapies in the Netherlands, as little resistance has developed to these antibiotics.
PURPOSE: To investigate the clinical presentation, isolated organism, treatment, and morbidity of contact lens-associated microbial keratitis needing hospitalization. METHODS: This retrospective study included all consecutive patients with contact lens-associated microbial keratitis hospitalized in the Rotterdam Eye Hospital from January 1, 2005, to December 31, 2009. All data regarding epidemiological characteristics, clinical presentation, isolated organism, and treatment were collected from medical records. RESULTS: There were 109 cases (108 patients) of contact lens-associated microbial keratitis hospitalized during the study period. Mean age was 33.3 ± 15.4 (SD) years. Pseudomonas aeruginosa was the most frequently isolated microorganism (68.8 %), with minor resistance to gentamicin (2.7 %) and ofloxacin (1.3 %). At time of presentation, best corrected visual acuity (BCVA) was very poor, with the largest proportion of patients (65.1 %) seeing worse than 0.05 Snellen. After intensive treatment, the visual outcome improved considerably, with the largest proportion (67.0 %) achieving a BCVA ≥ 0.7 Snellen. Low BCVA at admission was significantly associated with a worse final BCVA. A total of 22 patients (20.2 %) required corneal transplantation (three emergency cases). Larger size of stromal infiltrate was significantly associated with the need for corneal transplantation. CONCLUSION:Microbial keratitis is a serious complication of contact lens wear, with approximately one out of five hospitalized cases requiring corneal transplantation. Ofloxacin, or a combination of gentamicin and cephazolin, still appear to be excellent first-choice therapies in the Netherlands, as little resistance has developed to these antibiotics.
Authors: Fiona Stapleton; Lisa J Keay; Paul G Sanfilippo; Suchi Katiyar; Katie P Edwards; Thomas Naduvilath Journal: Am J Ophthalmol Date: 2007-08-29 Impact factor: 5.258
Authors: Lisa Keay; Katie Edwards; Thomas Naduvilath; Hugh R Taylor; Grant R Snibson; Kevin Forde; Fiona Stapleton Journal: Ophthalmology Date: 2005-12-19 Impact factor: 12.079
Authors: Ephigenia K Mela; Ioanna P Giannelou; John X Koliopoulos; Sotirios P Gartaganis; Koliopoulos X John; Gartaganis P Sotirios Journal: Eye Contact Lens Date: 2003-10 Impact factor: 2.018
Authors: E C Poggio; R J Glynn; O D Schein; J M Seddon; M J Shannon; V A Scardino; K R Kenyon Journal: N Engl J Med Date: 1989-09-21 Impact factor: 91.245
Authors: Oriel Spierer; Pedro F Monsalve; Terrence P OʼBrien; Eduardo C Alfonso; Daniel Gologorsky; Darlene Miller Journal: Cornea Date: 2016-05 Impact factor: 2.651
Authors: S Z Tan; A Walkden; L Au; C Fullwood; A Hamilton; A Qamruddin; M Armstrong; A K Brahma; F Carley Journal: Eye (Lond) Date: 2017-04-28 Impact factor: 3.775
Authors: Wahaj Saleem; Angela H Benton; Mary E Marquart; Shuli Wang; Waqas Saleem; Randy Vigil; Bo Huang; Anjal C Sharma Journal: Clin Plasma Med Date: 2019-12-27
Authors: Darren Shu Jeng Ting; Charlotte Shan Ho; Rashmi Deshmukh; Dalia G Said; Harminder S Dua Journal: Eye (Lond) Date: 2021-01-07 Impact factor: 3.775